All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Pharmaq signs financing of leveraged buy-out

Norwegian pharmaceutical company Pharmaq has signed a new Nkr815m ($139.6m) debt package. The senior credit facilities will serve to support private equity firm Permira’s acquisition of Pharmaq, refinance existing debt, and are also for general corporate purposes.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree